Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.37 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.37 |
| ▸ | LTA4H | P09960 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HTR1D | P28221 | 1/20 | 0.36 |
| ▸ | HTR1B | P28222 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1723277 | 0.80 | TDP1 (0.42) | LMNAALDH1A1RECQLTDP1KCNA3 | |
| SCHEMBL10345161 | 0.74 | MAPK1 (0.36) | LMNAALDH1A1MAPT | |
| SCHEMBL28914522 | 0.72 | ALDH1A1 (0.45) | LMNAALDH1A1RECQLTDP1KCNA3 | |
| SCHEMBL7253541 | 0.72 | TDP1 (0.44) | LMNATDP1KCNA3LTA4HHTR1D | |
| SCHEMBL28403653 | 0.71 | TDP1 (0.37) | LMNAALDH1A1RECQLTDP1KCNA3 | |
| SCHEMBL7156801 | 0.70 | TDP1 (0.40) | ALDH1A1RECQLTDP1KCNA3ALOX15 | |
| SCHEMBL28407786 | 0.70 | TDP1 (0.36) | LMNATDP1KCNA3LTA4HHTR1D | |
| SCHEMBL11013902 | 0.69 | ALDH1A1 (0.42) | LMNAALDH1A1RECQLTDP1KCNA3 | |
| Phenoxyethanol SCHEMBL11600634 | 0.68 | ALDH1A1 (0.54) | LMNAALDH1A1RECQLKCNA3HTR1D | |
| SCHEMBL24780612 | 0.68 | KCNA3 (0.44) | LMNAALDH1A1RECQLTDP1KCNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3520785-B1 | USES OF BACTERIOSTATIC AGENT FORMULA IN PREPARING COMPOSITION FOR VAGINAL USE AND COMPOSITION FOR VAGINAL USE | SHENZHEN EULIKAN BIOTECHNOLOGY CO LTD (CN) | 2024-07-17 | — | — | EP | claimed |
| EP-2774483-B1 | COMPOSITION CONTAINING SORBITAN MONOCAPRYLATE AND A SELECTED PYRIDONE | CLARIANT INT LTD (CH) | 2022-01-05 | — | — | EP | claimed |
| EP-3520785-A1 | USES OF BACTERIOSTATIC AGENT FORMULA IN PREPARING COMPOSITION FOR VAGINAL USE AND COMPOSITION FOR VAGINAL USE | Shenzhen Eulikan Biotechnology Co., Ltd. (CN) | 2019-08-07 | — | — | EP | claimed |
| US-20190231748-A1 | COMPOSITION FOR VAGINA AND ANTIMICROBIAL AGENT COMBINATION FOR USE IN PREPARING COMPOSITION FOR VAGINA | SINGAPORE ZE&Z INTERNATIONAL PTE. LTD. (SG) | 2019-08-01 | — | — | US | claimed |
| EP-2664237-A2 | Composition containing sorbitan monocaprylate and alcohol | Clariant Finance (BVI) Limited (VG) | 2013-11-20 | — | — | EP | claimed |
| EP-2432317-B1 | COMPOSITION CONTAINING SORBITAN MONOCAPRYLATE AND ALCOHOL | CLARIANT FINANCE BVI LTD (VG) | 2013-07-17 | — | — | EP | claimed |
| US-20120100085-A1 | COMPOSITION CONTAINING SORBITAN MONOCAPRYLATE AND ALCOHOL | CLARIANT FINANCE (BVI) LIMITED (VG) | 2012-04-26 | — | — | US | claimed |
| EP-2432317-A2 | COMPOSITION CONTAINING SORBITAN MONOCAPRYLATE AND ALCOHOL | Clariant Finance (BVI) Limited (VG) | 2012-03-28 | — | — | EP | claimed |
| WO-2010136120-A2 | COMPOSITION CONTAINING SORBITAN MONOCAPRYLATE AND ALCOHOL | CLARIANT INTERNATIONAL LTD (CH) | 2010-12-02 | — | — | WO | claimed |
| EP-3520785-B1 | USES OF BACTERIOSTATIC AGENT FORMULA IN PREPARING COMPOSITION FOR VAGINAL USE AND COMPOSITION FOR VAGINAL USE | SHENZHEN EULIKAN BIOTECHNOLOGY CO LTD (CN) | 2024-07-17 | — | — | EP | disclosed |
| WO-2024126876-A2 | ANTIMICROBIAL COMPOUNDS FOR ORAL CARE | CLARIANT INTERNATIONAL LTD (CH) | 2024-06-20 | — | — | WO | disclosed |
| WO-2024074693-A1 | BIO-BASED ANTIMICROBIAL COMPOUNDS | CLARIANT INTERNATIONAL LTD (CH) | 2024-04-11 | — | — | WO | disclosed |
| EP-4349806-A1 | BIO-BASED ANTIMICROBIAL COMPOUNDS | Clariant International Ltd (CH) | 2024-04-10 | — | — | EP | disclosed |
| WO-2023247803-A2 | ANTIMICROBIAL COMBINATIONS | CLARIANT INTERNATIONAL LTD (CH) | 2023-12-28 | — | — | WO | disclosed |
| US-20120101135-A1 | COMPOSITION CONTAINING SORBITAN MONOCAPRYLATE AND ANTIMICROBIAL SUBSTANCES | CLARIANT FINANCE (BVI) LIMITED (VG) | 2012-04-26 | — | — | US | disclosed |
| US-20120100085-A1 | COMPOSITION CONTAINING SORBITAN MONOCAPRYLATE AND ALCOHOL | CLARIANT FINANCE (BVI) LIMITED (VG) | 2012-04-26 | — | — | US | disclosed |
| EP-2432317-A2 | COMPOSITION CONTAINING SORBITAN MONOCAPRYLATE AND ALCOHOL | Clariant Finance (BVI) Limited (VG) | 2012-03-28 | — | — | EP | disclosed |
| EP-2432316-A2 | COMPOSITION CONTAINING SORBITAN MONOCAPRYLATE AND ANTIMICROBIAL SUBSTANCES | Clariant Finance (BVI) Limited (VG) | 2012-03-28 | — | — | EP | disclosed |
| WO-2010136121-A2 | COMPOSITION CONTAINING SORBITAN MONOCAPRYLATE AND ANTIMICROBIAL SUBSTANCES | CLARIANT INTERNATIONAL LTD (CH) | 2010-12-02 | — | — | WO | disclosed |
| WO-2010136120-A2 | COMPOSITION CONTAINING SORBITAN MONOCAPRYLATE AND ALCOHOL | CLARIANT INTERNATIONAL LTD (CH) | 2010-12-02 | — | — | WO | disclosed |